Patient Satisfaction in Relapsing-Remitting Multiple Sclerosis: Benefits of Home-Based Self-Administration of Subcutaneous Ofatumumab Compared to Other High-Efficacy Treatments - Top-Institutions - MDSpire

Patient Satisfaction in Relapsing-Remitting Multiple Sclerosis: Benefits of Home-Based Self-Administration of Subcutaneous Ofatumumab Compared to Other High-Efficacy Treatments

  • By

  • Francesco Pastore

  • Emanuela Domenicone

  • Patrizia DellOro

  • Charlotte Lefort

  • April 20, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Clinical Research

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Immunology

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Neuroimmunology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Clinical Trials

  • #5

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, MA

    Key Differentiators

    • Neurology
    • Multiple Sclerosis
    • Health Outcomes Research

Original Source(s)

Patient Satisfaction in Relapsing-Remitting Multiple Sclerosis: Benefits of Home-Based Self-Administration of Subcutaneous Ofatumumab Compared to Other High-Efficacy Treatments

  • by Francesco Pastore, Emanuela Domenicone, Patrizia DellOro, Charlotte Lefort

  • April 20, 2026

Related Content

Trust and anxiety as primary drivers of digital health acceptance in multiple sclerosis: toward an extended disease-specific technology acceptance model

Physical disability, cognition, and depression as determinants of quality of life in multiple sclerosis: a cross-sectional study

Editorial: Host-microbe immunometabolic chat: a new era of organismal communication